Cargando…
Corrigendum to “Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447590/ https://www.ncbi.nlm.nih.gov/pubmed/32879895 http://dx.doi.org/10.1155/2020/5106904 |
Ejemplares similares
-
Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils
por: Yuan, Ming, et al.
Publicado: (2016) -
Corrigendum to “New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy”
por: Guo, Qiujun, et al.
Publicado: (2018) -
Corrigendum to “Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer”
por: Jiang, Tao, et al.
Publicado: (2020) -
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023) -
Corrigendum to “Recurrent Syncope Associated with Lung Cancer”
por: Zhang, Dingguo, et al.
Publicado: (2016)